{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:26:07Z","timestamp":1771489567793,"version":"3.50.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this study we investigated telomere restriction fragment (TRF) length in a panel of mature B-cell lymphoproliferative disorders (MBCLDs) and correlated this parameter with histology and histopathogenesis in relation to the germinal center (GC). We assessed 123 MBCLD samples containing 80% or more tumor cells. TRF length was evaluated by Southern blot analysis using a chemiluminescence-based assay. GC status was assessed through screening for stable and ongoing somatic mutations within the immunoglobulin heavy-chain genes. Median TRF length was 6170 bp (range, 1896-11 200 bp) and did not correlate with patient age or sex. TRF length was greater in diffuse large cell lymphoma, Burkitt lymphoma, and follicular lymphoma (medians: 7789 bp, 9471 bp, and 7383 bp, respectively) than in mantle cell lymphoma and chronic lymphocytic leukemia (medians: 3582 bp and 4346 bp, respectively). GC-derived MBCLDs had the longest telomeres, whereas those arising from GC-inexperienced cells had the shortest (P &amp;lt; 10-9). We conclude that (1) TRF length in MBCLD is highly heterogeneous; (2) GC-derived tumors have long telomeres, suggesting that minimal telomere erosion occurs during GC-derived lymphomagenesis; and (3) the short TRF lengths of GC-inexperienced MBCLDs indicates that these neoplasms are good candidates for treatment with telomerase inhibitors, a class of molecules currently the subject of extensive preclinical evaluation. (Blood. 2004;103:4644-4649)<\/jats:p>","DOI":"10.1182\/blood-2003-12-4412","type":"journal-article","created":{"date-parts":[[2004,3,2]],"date-time":"2004-03-02T01:45:31Z","timestamp":1078191931000},"page":"4644-4649","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders"],"prefix":"10.1182","volume":"103","author":[{"given":"Marco","family":"Ladetto","sequence":"first","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Compagno","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Ricca","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pagano","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Rocci","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Astolfi","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Drandi","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Francia","family":"di Celle","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Dell'Aquila","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mantoan","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Vallet","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Pagliano","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"De Marco","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Francese","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Santo","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cuttica","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Marinone","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Tarella","sequence":"additional","affiliation":[{"name":"From the Divisione di Ematologia, Dipartimento di Medicina ed Oncologia Sperimentale, and the Divisione di Anatomia Patologica, Dipartimento di Scienze Biomediche ed Oncologia Umana, Universita\u0300 di Torino, Azienda Ospedaliera S. Giovanni Battista, Turin; and the Divisione di Medicina Generale VII, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021219210806600_REF1","doi-asserted-by":"crossref","unstructured":"Hahn WC. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol. 2003;21: 2034-2043.","DOI":"10.1200\/JCO.2003.06.018"},{"key":"2020021219210806600_REF2","doi-asserted-by":"crossref","unstructured":"McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet. 2000;34: 331-358.","DOI":"10.1146\/annurev.genet.34.1.331"},{"key":"2020021219210806600_REF3","doi-asserted-by":"crossref","unstructured":"Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A. 1988;85: 6622-6626.","DOI":"10.1073\/pnas.85.18.6622"},{"key":"2020021219210806600_REF4","doi-asserted-by":"crossref","unstructured":"Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci U S A. 1989;86: 7049-7053.","DOI":"10.1073\/pnas.86.18.7049"},{"key":"2020021219210806600_REF5","doi-asserted-by":"crossref","unstructured":"Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89: 10114-10118.","DOI":"10.1073\/pnas.89.21.10114"},{"key":"2020021219210806600_REF6","doi-asserted-by":"crossref","unstructured":"Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91: 25-34.","DOI":"10.1016\/S0092-8674(01)80006-4"},{"key":"2020021219210806600_REF7","doi-asserted-by":"crossref","unstructured":"Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345: 458-460.","DOI":"10.1038\/345458a0"},{"key":"2020021219210806600_REF8","doi-asserted-by":"crossref","unstructured":"Yu GL, Bradley JD, Attardi LD, et al. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 1990;344: 126-132.","DOI":"10.1038\/344126a0"},{"key":"2020021219210806600_REF9","doi-asserted-by":"crossref","unstructured":"Sedivy JM. Can ends justify the means? telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc Natl Acad Sci U S A. 1997;95: 9078-9081.","DOI":"10.1073\/pnas.95.16.9078"},{"key":"2020021219210806600_REF10","doi-asserted-by":"crossref","unstructured":"Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med1999;5: 1164-1170.","DOI":"10.1038\/13495"},{"key":"2020021219210806600_REF11","doi-asserted-by":"crossref","unstructured":"Shay JW, Wright WE. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res. 1989;184: 109-118.","DOI":"10.1016\/0014-4827(89)90369-8"},{"key":"2020021219210806600_REF12","doi-asserted-by":"crossref","unstructured":"Wei W, Sedivy JM. Differentiation between senescence (M1) and crisis (M2) in human fibroblast cultures. Exp Cell Res. 1999;253: 519-522.","DOI":"10.1006\/excr.1999.4665"},{"key":"2020021219210806600_REF13","doi-asserted-by":"crossref","unstructured":"Halvorsen TL, Leibowitz G, Levine F. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol. 1999;19: 1864-1870.","DOI":"10.1128\/MCB.19.3.1864"},{"key":"2020021219210806600_REF14","doi-asserted-by":"crossref","unstructured":"Ramakrishnan S, Sharma HW, Farris AD, et al. Characterization of human telomerase complex. Proc Natl Acad Sci U S A. 1997;94: 10075-10079.","DOI":"10.1073\/pnas.94.19.10075"},{"key":"2020021219210806600_REF15","doi-asserted-by":"crossref","unstructured":"Hiyama E, Hiyama K, Tatsumoto N, et al. Telomerase activity in human intestine. Int J Oncol. 1996;9: 453-458.","DOI":"10.3892\/ijo.9.3.453"},{"key":"2020021219210806600_REF16","unstructured":"Yasumoto S, Kunimura C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogene. 1996;13: 433-439."},{"key":"2020021219210806600_REF17","doi-asserted-by":"crossref","unstructured":"Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A. 1996;93: 6476-6481.","DOI":"10.1073\/pnas.93.13.6476"},{"key":"2020021219210806600_REF18","doi-asserted-by":"crossref","unstructured":"Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood. 1998;91: 3255-3262.","DOI":"10.1182\/blood.V91.9.3255"},{"key":"2020021219210806600_REF19","doi-asserted-by":"crossref","unstructured":"Weng NO, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A. 1997;94: 10827-10832.","DOI":"10.1073\/pnas.94.20.10827"},{"key":"2020021219210806600_REF20","doi-asserted-by":"crossref","unstructured":"Butler MG, Sciadini M, Hedges LK, et al. Chromosome telomere integrity of human solid neoplasms. Cancer Genet Cytogenet. 1996;86: 50-53.","DOI":"10.1016\/0165-4608(95)00142-5"},{"key":"2020021219210806600_REF21","doi-asserted-by":"crossref","unstructured":"Djojosubroto MW, Choi YS, Lee HW, et al. Telomeres and telomerase in aging, regeneration and cancer. Mol Cells. 2003;15: 164-175.","DOI":"10.1016\/S1016-8478(23)13723-X"},{"key":"2020021219210806600_REF22","doi-asserted-by":"crossref","unstructured":"Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266: 2011-2015.","DOI":"10.1126\/science.7605428"},{"key":"2020021219210806600_REF23","doi-asserted-by":"crossref","unstructured":"Kim SH, Kaminker P, Campisi J. Telomeres, aging and cancer: in search of a happy ending. Oncogene. 2002;21: 503-511.","DOI":"10.1038\/sj.onc.1205077"},{"key":"2020021219210806600_REF24","doi-asserted-by":"crossref","unstructured":"Klaus D, Ulrike H, Pilar G-C, et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 2001;20: 6958-6968.","DOI":"10.1093\/emboj\/20.24.6958"},{"key":"2020021219210806600_REF25","doi-asserted-by":"crossref","unstructured":"Pascolo E, Wenz C, Lingner J, et al. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem. 2002;277: 15566-15572.","DOI":"10.1074\/jbc.M201266200"},{"key":"2020021219210806600_REF26","doi-asserted-by":"crossref","unstructured":"Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett. 2003;194: 209-219.","DOI":"10.1016\/S0304-3835(02)00708-5"},{"key":"2020021219210806600_REF27","doi-asserted-by":"crossref","unstructured":"Wu KD, Orme LM, Shaughnessy J, et al. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood. 2003;101: 4982-4989.","DOI":"10.1182\/blood-2002-11-3451"},{"key":"2020021219210806600_REF28","unstructured":"Bechter OE, Eisterer W, Pall G, et al. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res. 1998;58: 4918-4922."},{"key":"2020021219210806600_REF29","doi-asserted-by":"crossref","unstructured":"Damle RN, Batliwalla FM, Ghiotto F, et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by Ig V gene mutations. Blood. 2003 [Epub ahead of print].","DOI":"10.1182\/blood-2003-04-1345"},{"key":"2020021219210806600_REF30","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2014Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17: 3835-3849.","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"2020021219210806600_REF31","doi-asserted-by":"crossref","unstructured":"Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87: 4990-4997.","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990"},{"key":"2020021219210806600_REF32","unstructured":"Harley CB. Telomeres and aging. In: Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1995."},{"key":"2020021219210806600_REF33","doi-asserted-by":"crossref","unstructured":"Lansdorp PM, Verwoerd NP, van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet. 1996;5: 685-691.","DOI":"10.1093\/hmg\/5.5.685"},{"key":"2020021219210806600_REF34","doi-asserted-by":"crossref","unstructured":"Ladetto M, Donovan JW, Harig S, et al. Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma. Biol Blood Marrow Transplant. 2000;6: 241-253.","DOI":"10.1016\/S1083-8791(00)70006-1"},{"key":"2020021219210806600_REF35","doi-asserted-by":"crossref","unstructured":"Donovan JW, Ladetto M, Zou G, et al. Immunoglobulin heavy-chain consensus probes for realtime PCR quantification of residual disease in acute lymphoblastic leukemia. Blood. 2000;95: 2651-2658.","DOI":"10.1182\/blood.V95.8.2651"},{"key":"2020021219210806600_REF36","doi-asserted-by":"crossref","unstructured":"Ladetto M, Omede P, Sametti S, et al. Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests. Exp Hematol. 2002;30: 529-536.","DOI":"10.1016\/S0301-472X(02)00794-4"},{"key":"2020021219210806600_REF37","doi-asserted-by":"crossref","unstructured":"Voena C, Ladetto M, Astolfi M, et al. A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia. 1997;11: 1793-1798.","DOI":"10.1038\/sj.leu.2400801"},{"key":"2020021219210806600_REF38","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99: 1023-1029.","DOI":"10.1182\/blood.V99.3.1023"},{"key":"2020021219210806600_REF39","doi-asserted-by":"crossref","unstructured":"Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood. 2003;102: 1833-1841.","DOI":"10.1182\/blood-2002-11-3606"},{"key":"2020021219210806600_REF40","doi-asserted-by":"crossref","unstructured":"Capello D, Cerri M, Muti G, et al. Molecular histogenesis of posttransplant lymphoproliferative disorders. Blood. 2003 [Epub ahead of print].","DOI":"10.1182\/blood-2003-05-1683"},{"key":"2020021219210806600_REF41","doi-asserted-by":"crossref","unstructured":"Lossos IS, Alizadeh AA, Eisen MB, et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A. 2000;97: 10209-10213.","DOI":"10.1073\/pnas.180316097"},{"key":"2020021219210806600_REF42","doi-asserted-by":"crossref","unstructured":"Oeschger S, Bra\u0308uninger A, Ku\u0308ppers R, et al. Tumor cell dissemination in follicular lymphoma. Blood. 2002;99: 2192-2198.","DOI":"10.1182\/blood.V99.6.2192"},{"key":"2020021219210806600_REF43","doi-asserted-by":"crossref","unstructured":"Hultdin M, Rosenquist R, Thunberg U, et al. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer. 2003;88: 593-598.","DOI":"10.1038\/sj.bjc.6600763"},{"key":"2020021219210806600_REF44","doi-asserted-by":"crossref","unstructured":"Norrback KF, Hultdin M, Dahlenborg K, et al. Telomerase regulation and telomere dynamics in germinal centers. Eur J Haematol. 2001;67: 309-317.","DOI":"10.1034\/j.1600-0609.2001.00588.x"},{"key":"2020021219210806600_REF45","doi-asserted-by":"crossref","unstructured":"MacKenzie KL, Franco S, Naiyer AJ, et al. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene. 2002;21: 4200-4211.","DOI":"10.1038\/sj.onc.1205425"},{"key":"2020021219210806600_REF46","doi-asserted-by":"crossref","unstructured":"Remes K, Norrback KF, Rosenquist R, et al. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer. 2000;82: 601-607.","DOI":"10.1054\/bjoc.1999.0970"},{"key":"2020021219210806600_REF47","doi-asserted-by":"crossref","unstructured":"Damm K, Hemmann U, Garin-Chesa P, et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 2001;20: 6958-6968.","DOI":"10.1093\/emboj\/20.24.6958"},{"key":"2020021219210806600_REF48","doi-asserted-by":"crossref","unstructured":"Nakajima A, Tauchi T, Sashida G, et al. Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia. 2003;17: 560-567.","DOI":"10.1038\/sj.leu.2402825"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4644\/1698521\/zh801204004644.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4644\/1698521\/zh801204004644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T15:56:12Z","timestamp":1705074972000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/12\/4644\/131417\/Telomere-length-correlates-with-histopathogenesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-12-4412","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}